Pharmalogical Consideration of Infectious Disease and Agents

Pandemic, epidemic and endemic infectious diseases are united by a standard problem: how do we quickly and cost-effectively determine potential pharmacological arbitration to treat infections? The growing accessibility of parasite genome data provides the basis for developing methods to prioritize, a priori potential drug targets and analyze the pharmacological landscape of an infectious disease. Infectious diseases create totally different threats to different constituencies and thus are often treated as separate problems by governments, businesses, philanthropies and research funders: neglected diseases are treated as  world health problems; emerging and pandemic diseases  as public health issues; and bio-defence as a national security issue.

    Related Conference of Pharmalogical Consideration of Infectious Disease and Agents

    November 19-19, 2021

    11th European Epidemiology and Public Health Congress

    Paris, France
    December 01-01, 2021

    4th International Conference on Tropical and Infectious Diseases

    Amsterdam, Netherlands
    February 07-08, 2022

    9th International Congress on Infectious Diseases

    Aberdeen, UK
    March 09-10, 2022

    VIROLOGY CONFERENCE-INFE-2022

    Geneva, Switzerland
    April 25-26, 2022

    4th World Congress on Advancements in Tuberculosis and Lung Diseases

    Singapore City, Singapore
    June 24-25, 2022

    14th Euro-Global Conference on Infectious Diseases

    Berlin, Aland Islands

    Pharmalogical Consideration of Infectious Disease and Agents Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in